Source:http://linkedlifedata.com/resource/pubmed/id/10534184
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1999-11-17
|
pubmed:abstractText |
An observational cohort study was performed to assess the effectiveness of a cytomegalovirus antigenemia (CMV-Ag) assay designed to predict clinical CMV disease in patients with AIDS. Eighty-six HIV-infected patients with CD4+ cell counts of < 100/mm3, positive CMV IgG, and no previous CMV disease were enrolled. Thirty-eight (44%) patients had at least one positive CMV antigenemia test, ten of whom eventually developed CMV focal disease. CMV disease was diagnosed in 13 (15%) patients. The CMV antigenemia assay was positive in ten of these 13 patients. Using a cut-off value of five positive cells in every 150,000 leukocytes sampled, the CMV antigenemia assay had a positive predictive value of 89% and a negative predictive value of 94%. The median time from the first positive CMV antigenemia test to the onset of CMV disease was 102 days. CMV disease probability at 6 months in patients with a CMV antigenemia value > or = 5 was 77.8% versus 6% in patients with CMV antigenemia value < 5 (log-rank test = 48.345; P < 0.001). Several independent factors were associated with the development of CMV disease: CMV antigenemia > or = 5 cells (hazard ratio: 20.44), CD4+ count < or = 25/mm3 (HR: 3.12), and sexual transmission of HIV infection (hazard ratio, 3.15). CMV antigenemia seems to be a good predictor of CMV disease in patients with AIDS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/cytomegalovirus matrix protein 65kDa
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0934-9723
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
630-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10534184-AIDS-Related Opportunistic Infections,
pubmed-meshheading:10534184-Adult,
pubmed-meshheading:10534184-Antigens, Viral,
pubmed-meshheading:10534184-CD4 Lymphocyte Count,
pubmed-meshheading:10534184-Cytomegalovirus,
pubmed-meshheading:10534184-Cytomegalovirus Infections,
pubmed-meshheading:10534184-DNA, Viral,
pubmed-meshheading:10534184-Female,
pubmed-meshheading:10534184-Humans,
pubmed-meshheading:10534184-Male,
pubmed-meshheading:10534184-Middle Aged,
pubmed-meshheading:10534184-Phosphoproteins,
pubmed-meshheading:10534184-Polymerase Chain Reaction,
pubmed-meshheading:10534184-Viral Matrix Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
|
pubmed:affiliation |
Servicio de Medicina Interna, Sección de Enfermedades Infecciosas, Hospital General Universitario de Alicante, Spain. karmen@umh.es
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|